1. A mammalian cell regulatory agent, CeReS-18, inhibits yeast cell proliferation but not bacterial replication.
- Author
-
An K, Urban DB, Urban JE, and Johnson TC
- Subjects
- 3T3 Cells drug effects, Animals, Bacillus cereus growth & development, Cattle, Cell Cycle, Cell Division drug effects, Cyclin-Dependent Kinases antagonists & inhibitors, Escherichia coli growth & development, Mice, Saccharomyces cerevisiae cytology, Schizosaccharomyces cytology, Bacillus cereus drug effects, Escherichia coli drug effects, Saccharomyces cerevisiae drug effects, Schizosaccharomyces drug effects, Sialoglycoproteins pharmacology
- Abstract
A cell regulatory sialoglycopeptide, CeReS-18, purified from intact bovine cerebral cortex cells, has exhibited the capability of reversibly inhibiting cellular DNA synthesis and the proliferation of a wide array of mammalian cells. In the present study, the effect of CeReS-18 on the proliferation of bacterial ( Bacillus cereus and Escherichia coli) and yeast ( Saccharomyces cerevisiae and Schizosaccharomyces pombe) cells was investigated. The results showed that replication and viability of the bacterial cells were not affected by CeReS-18 at any concentration tested, including 15-fold higher than that used for inhibiting mouse 3T3 cell proliferation. In contrast to bacterial cells, CeReS-18 was able to inhibit the replication of yeast cells, in a concentration-dependent, reversible manner, and the addition of calcium to the culture medium could abrogate the inhibitory effect of CeReS-18. A cytotoxic effect of CeReS-18 on both yeast cell species was observed when it was applied at higher concentrations.
- Published
- 2003
- Full Text
- View/download PDF